Elisabeth Whitney
Chief Operating Officer at Trellis Bioscience.
Raised on Trellis Bioscience filings
$6.1M
across 1 Form D filing
- Form D filings
- 1
- Teammates
- 4
- Last filing
- May 15, 2026
Company
Trellis Bioscience
Biotech · Redwood City, CA
Biofilm-disrupting antibodies for chronic joint infections
Biofilm-disrupting antibodies for chronic joint infections
- Investors
- 16
Trellis Bioscience filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| May 15, 2026 | Equity | $6.1M/ no target | Form D |
- EquityFiled May 15, 2026Form D$6.1M/ no target
